Biome Australia (ASX:BIO), a probiotic and health products company, is held by Saville Capital through a recent sell-off. In July 2026, Saville reported fourth-quarter FY26 cash receipts of $5.9 million, up 23% on the prior quarter and 61% on the prior year, taking FY26 revenue to $23.9 million, up 30%, driven by practitioner sales growth. Saville noted Biome signed an agreement to manufacture its Activated Probiotics range onshore, and that the shares halved over eight months amid tax-loss selling, prompting it to add. Biome Australia operates in the Consumer Staples sector within the Personal Products industry, and Thesis Tracker has captured 8 comments from 1 fund manager, Saville Capital. Founded in 2018 and headquartered in Collingwood, Melbourne, Biome develops, manufactures and distributes evidence-based probiotic and complementary medicines, including Activated Probiotics, sold through healthcare practitioners and pharmacies in Australia, New Zealand and the UK.